Cleancision IntRaoperative Contamination prEvention Study
NCT ID: NCT02413879
Last Updated: 2017-07-27
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
108 participants
INTERVENTIONAL
2015-03-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective, Randomized, Parallel-arm Clinical Trial of CleanCision or Alexis O in Elective Colorectal Surgery
NCT03816995
Application of PREVENA in Reducing Surgical Site Complications Following Reversal of Ileostomy or Colostomy
NCT04974931
Plastic Wound Retractors and Bacterial Translocation in Abdominal Surgery
NCT01007487
Use of Negative Pressure Wound Therapy in High Risk Surgical Closed Incisions
NCT02137447
Prophylaxis of Surgical Wound Infection With Topical Antibiotics
NCT04476212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a prospective, multi-center, single-arm (non-randomized) clinical study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment Group
All study subjects will be treated using the CleanCision device.
CleanCision
Wound protection during colorectal surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CleanCision
Wound protection during colorectal surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 15-45, inclusive
* Colorectal surgery patient, planned resection
* Incision length meets labeling requirements
* Written informed consent using the governing IRB approved form
Exclusion Criteria
* Patients undergoing emergent colorectal surgery
* Known history of contact hypersensitivity or allergy to device materials
* Prior laparotomy or abdominal surgery within a timeframe that may present a safety risk or compromise study results
* Active infection, sepsis or systemic antibiotic therapy within timeframe that may impact safety or study results
* Active participation in any other clinical study of an experimental drug or device that may impact safety or study results
* Postsurgical life expectancy is less than the study follow up period
* Subject is pregnant or lactating
* Subject is under incarceration
* Subject considered to be inoperable following exploratory surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prescient Surgical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Harry Papaconstantinou, MD
Role: PRINCIPAL_INVESTIGATOR
Scott & White Memorial Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
Lahey Hospital and Medical Center
Burlington, Massachusetts, United States
Washington University Medical Center
St Louis, Missouri, United States
Stony Brook Medicine
Stony Brook, New York, United States
Baylor University Medical Center
Dallas, Texas, United States
Scott & White Memorial Hospital
Temple, Texas, United States
Intermountain Healthcare McKay-Dee Hospital
Ogden, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Papaconstantinou HT, Ricciardi R, Margolin DA, Bergamaschi R, Moesinger RC, Lichliter WE, Birnbaum EH. A Novel Wound Retractor Combining Continuous Irrigation and Barrier Protection Reduces Incisional Contamination in Colorectal Surgery. World J Surg. 2018 Sep;42(9):3000-3007. doi: 10.1007/s00268-018-4568-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLP-0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.